By Dan Bobear (@dbobear)
Now that AstraZeneca’s experimental blood thinner Brilinta has been given the green light by an advisory committee of the U.S. Food and Drug Administration, they need to prepare for the next hurdle they face: usurping category leader, Plavix, which is slated for generic availability sometime next year.
Most critical: changing physician prescribing behavior.
The [...]
Tags:AstraZeneca·audience·Blogs·branding·Facebook·image·interaction·location-based·marketing·Patients·physicians·social media·Twitter·YouTube
Earl D. Whipple is the Senior Director of Business Communications and Digital Media for AstraZeneca. In an effort to drive online visibility and digital engagement for one of the world’s leading biopharmaceutical companies, Earl and his team launched AstraZeneca’s first company blog and Facebook community. Today, Pixels & Pills talks to Earl about Pharma’s obligation [...]
Tags:AstraZeneca·Blogs·corporate social responsibility·Earl Whipple·Education·Facebook·FDA·healthcare community·marketing·media·Pharma·Pharmaceutical industry·social media·technology·Thought Leaders·Trends
